The use of pharmacoeconomic data in hospital formulary decisions was explored. Data were collected from pharmacist members of pharmacy and therapeutics (P&T) committees in 204 Florida hospitals.

Pharmacoeconomic Analyses of Drug Alternatives for the Management of Acute Agitation in the ED: The Considerations In the decision-analytic model, health outcomes and/or costs are assigned to each ...

At the present the biochemical properties of hyaluronan that provide the symptomatic and improved function in some patients is not known. Pharmacoeconomic studies are urgently required given the ...

Experiences include, but are not limited to, pharmacokinetics/ pharmacodynamics, medical microbiology, antimicrobial monitoring, pharmacoeconomic issues with antimicrobial therapy, and infection ...

and pharmacoeconomic analysis. Joseph’s most recent experience was in leading the oncology medical affairs team for a large Fortune 100 pharmaceutical company in the US. In this capacity ...

Introduction China faces the dual challenge of high air pollution and an increasing burden of cardiovascular disease (CVD). We aimed to estimate the healthcare costs associated with CVD and the ...